Product Pathways
BCP0108 Rivaroxaban(Xarelto)
A novel, oral, direct Factor Xa (FXa) inhibitor in late-stage development for the prevention and treatment of thromboembolic disorders.
BCP0140 Y27632
Selective inhibitor of the Rho-associated protein kinase p160ROCK.
BCP0270 GSK429286A
GSK429286A is a cell-permeable, selective inhibitor of Rho-associated kinase (ROCK).
BCP0271 SR 3677
Potent and selective Rho-kinase inhibitor (IC50 values are 3 and 56 nM for ROCK-II and ROCK-I respectively).
BCP000719 Thiazovivin
Thiazovivin dramatically improves the survival of hESCs upon trypsinization1.
BCP000773 Apixaban
Apixaban is a direct factor Xa inhibitor with an IC50 of 0.22±0.02 M.
BCP000911 Fasudil hydrochloride
Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.
BCP001077 BMS740808
BCP0006536 Y27632 (hydrochloride)
BCP0004267 Edoxaban
第一页 1 2 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.